SG47725A1 - Combination pediatric vaccine with enhanced immunogenicity of each vaccine component - Google Patents

Combination pediatric vaccine with enhanced immunogenicity of each vaccine component

Info

Publication number
SG47725A1
SG47725A1 SG1996004072A SG1996004072A SG47725A1 SG 47725 A1 SG47725 A1 SG 47725A1 SG 1996004072 A SG1996004072 A SG 1996004072A SG 1996004072 A SG1996004072 A SG 1996004072A SG 47725 A1 SG47725 A1 SG 47725A1
Authority
SG
Singapore
Prior art keywords
vaccine
enhanced immunogenicity
component
combined
pediatric
Prior art date
Application number
SG1996004072A
Other languages
English (en)
Inventor
Peter R Paradiso
Deborah A Hogerman
Dace Viceps Madore
Jill G Hackell
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of SG47725A1 publication Critical patent/SG47725A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
SG1996004072A 1992-10-27 1993-07-22 Combination pediatric vaccine with enhanced immunogenicity of each vaccine component SG47725A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US96699592A 1992-10-27 1992-10-27

Publications (1)

Publication Number Publication Date
SG47725A1 true SG47725A1 (en) 1998-04-17

Family

ID=25512167

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996004072A SG47725A1 (en) 1992-10-27 1993-07-22 Combination pediatric vaccine with enhanced immunogenicity of each vaccine component

Country Status (23)

Country Link
EP (1) EP0594950B1 (es)
JP (1) JPH07300427A (es)
KR (1) KR100289224B1 (es)
AT (1) ATE176157T1 (es)
AU (1) AU669570B2 (es)
CA (1) CA2109159A1 (es)
CZ (1) CZ283587B6 (es)
DE (2) DE69323264D1 (es)
DK (1) DK0594950T3 (es)
ES (1) ES2126616T3 (es)
FI (1) FI934725A (es)
GR (1) GR3029884T3 (es)
HK (1) HK1009931A1 (es)
HU (1) HU215149B (es)
IL (1) IL107387A (es)
LV (1) LV12271B (es)
NO (1) NO308588B1 (es)
NZ (1) NZ250029A (es)
PL (1) PL174130B1 (es)
RU (1) RU2121365C1 (es)
SG (1) SG47725A1 (es)
TW (1) TW256774B (es)
UA (1) UA27754C2 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1864195A (en) * 1994-03-07 1995-09-25 Auckland Uniservices Limited Prevention of diabetes
DK1090642T3 (da) * 1995-06-07 2008-09-22 Glaxosmithkline Biolog Sa Vacciner omfattende et polysaccharidantigen-bæreprotein-konjugat og frit bæreprotein
EP0833662B2 (en) * 1995-06-23 2011-01-26 SmithKline Beecham Biologicals S.A. A vaccine composition comprsing a Haemophilus influenzae B polysaccharide conjugate antigen adsorbed onto aluminium phosphate
US20020054884A1 (en) 1995-06-23 2002-05-09 Smithkline Beecham Biologicals, Sa Vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate
CN100408095C (zh) * 1996-07-02 2008-08-06 康诺特实验室有限公司 多价dtp-polio疫苗
GB0108364D0 (en) * 2001-04-03 2001-05-23 Glaxosmithkline Biolog Sa Vaccine composition
EA006313B1 (ru) * 2000-06-29 2005-10-27 Глаксосмитклайн Байолоджикалс С.А. Поливалентные иммуногенные композиции и способы их применения
DE60311526T2 (de) 2002-11-01 2007-10-31 Glaxosmithkline Biologicals S.A. Immunogene zusammensetzung
GB0505996D0 (en) * 2005-03-23 2005-04-27 Glaxosmithkline Biolog Sa Fermentation process
KR20130122810A (ko) 2005-06-27 2013-11-08 글락소스미스클라인 바이오로지칼즈 에스.에이. 백신 제조 방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4902506A (en) * 1983-07-05 1990-02-20 The University Of Rochester Immunogenic conjugates

Also Published As

Publication number Publication date
DE69323264T2 (de) 1999-06-02
HU215149B (hu) 2000-03-28
TW256774B (es) 1995-09-11
LV12271A (lv) 1999-05-20
HK1009931A1 (en) 1999-06-11
IL107387A (en) 1997-04-15
HU9303028D0 (en) 1994-01-28
GR3029884T3 (en) 1999-07-30
FI934725A0 (fi) 1993-10-26
NO933856D0 (no) 1993-10-26
CA2109159A1 (en) 1994-04-28
KR100289224B1 (ko) 2001-05-02
FI934725A (fi) 1994-04-28
IL107387A0 (en) 1994-01-25
ES2126616T3 (es) 1999-04-01
DK0594950T3 (da) 1999-09-13
NZ250029A (en) 1994-09-27
PL174130B1 (pl) 1998-06-30
CZ283587B6 (cs) 1998-05-13
DE69323264T4 (de) 1999-10-14
LV12271B (en) 1999-07-20
RU2121365C1 (ru) 1998-11-10
JPH07300427A (ja) 1995-11-14
AU669570B2 (en) 1996-06-13
CZ227293A3 (en) 1994-05-18
UA27754C2 (uk) 2000-10-16
EP0594950A1 (en) 1994-05-04
NO933856L (no) 1994-04-28
EP0594950B1 (en) 1999-01-27
ATE176157T1 (de) 1999-02-15
DE69323264D1 (de) 1999-03-11
HUT67239A (en) 1995-03-28
AU5029093A (en) 1994-05-12
KR940008698A (ko) 1994-05-16
NO308588B1 (no) 2000-10-02

Similar Documents

Publication Publication Date Title
AU696338B2 (en) A vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate
BR9710460A (pt) Composi-Æo imunolÄgica multi-valente e seu uso em vacinas
CA2198251A1 (en) Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections
HK1055244A1 (en) Multivalent vaccine composition
HU913103D0 (en) Method for producing vaccines of oligosacharide conjugates
WO1989006974A3 (en) T-cell epitope as carriers molecule for conjugate vaccines
SG47725A1 (en) Combination pediatric vaccine with enhanced immunogenicity of each vaccine component
RU93048161A (ru) Комбинированная педиатрическая вакцина с усиленной иммуногенностью каждого вакционного компонента
EP0338265A3 (en) Haemophilus influenzae type b polysaccharide-outer membrane protein conjugate vaccine
WO1997035613A1 (en) Method of producing immunogenic products and vaccines
Audibert et al. Of antigens, adjuvants, and carriers in synthetic vaccines.
Egorkov et al. Immunological activity of small doses of diphtheria and tetanus toxoids in booster immunization of children with allergically altered responsiveness and adults.
Guo et al. Studies on meningococcal polysaccharide-tetanus toxoid conjugates.